| Recruiting | Hypofractionated Radiotherapy for the Treatment of Locally Advanced Cervical Cancer in Uganda NCT07276360 | Uganda Cancer Institute | Phase 2 |
| Recruiting | AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors NCT07454642 | Avacta Life Sciences Ltd | Phase 1 |
| Recruiting | External Beam Radiation Therapy and Brachytherapy With Chemotherapy and Immunotherapy for the Treatment of Sta NCT06543576 | Jonsson Comprehensive Cancer Center | Phase 1 / Phase 2 |
| Not Yet Recruiting | Pembrolizumab Concurrent With and Following Carbon-ion Radiotherapy for Locally Advanced Cervical Adenocarcino NCT06805864 | Gunma University | Phase 2 |
| Active Not Recruiting | RT for Adenocarcinoma/Adenosquamous Carcinoma NCT07153952 | Peking Union Medical College Hospital | Phase 1 / Phase 2 |
| Withdrawn | Testing the Addition of Paclitaxel and Carboplatin Given After Standard Chemotherapy and Radiation for Cervica NCT03834571 | AIDS Malignancy Consortium | Phase 2 |
| Active Not Recruiting | Human Papilloma Virus (HPV) Circulating Tumor DNA (ctDNA) in Cervical Cancer NCT04574635 | Mayo Clinic | — |
| Active Not Recruiting | Yoga Therapy During Chemotherapy and Radiation Treatment for the Improvement of Physical and Emotional Well-Be NCT04622670 | M.D. Anderson Cancer Center | N/A |
| Completed | Atezolizumab Before and/or With Chemoradiotherapy in Immune System Activation in Patients With Node Positive S NCT03738228 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Atezolizumab and Bevacizumab in Treating Patients With Recurrent, Persistent, or Metastatic Cervical Cancer NCT02921269 | National Cancer Institute (NCI) | Phase 2 |
| Active Not Recruiting | Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) Duri NCT02466971 | National Cancer Institute (NCI) | Phase 3 |
| Active Not Recruiting | Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer NCT02257528 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cance NCT02020707 | Mayo Clinic | Phase 1 |
| Terminated | MRI and PET Imaging in Predicting Treatment Response in Patients With Stage IB-IVA Cervical Cancer NCT01992861 | University of Washington | — |
| Active Not Recruiting | Studying the Physical Function and Quality of Life Before and After Surgery in Patients With Stage I Cervical NCT01649089 | GOG Foundation | N/A |
| Completed | Hybrid PET/MR in the Therapy of Cervical Cancer NCT01759355 | UNC Lineberger Comprehensive Cancer Center | — |
| Completed | Chemoradiation Therapy and Ipilimumab in Treating Patients With Stages IB2-IIB or IIIB-IVA Cervical Cancer NCT01711515 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced C NCT01414608 | GOG Foundation | Phase 3 |
| Completed | Vaccine Therapy in Treating Patients With Persistent or Recurrent Cervical Cancer NCT01266460 | Gynecologic Oncology Group | Phase 2 |
| Unknown | Cisplatin and Radiation Therapy Followed by Paclitaxel and Carboplatin in Treating Patients With Stage IB-IVA NCT01295502 | Gynecologic Oncology Group | Phase 1 |
| Completed | Brivanib Alaninate in Treating Patients With Persistent or Recurrent Cervical Cancer NCT01267253 | Gynecologic Oncology Group | Phase 2 |
| Completed | Paclitaxel, Cisplatin, and Veliparib in Treating Patients With Advanced, Persistent, or Recurrent Cervical Can NCT01281852 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Veliparib, Topotecan Hydrochloride, and Filgrastim or Pegfilgrastim in Treating Patients With Persistent or Re NCT01266447 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Radiation Therapy With or Without Chemotherapy in Patients With Stage I-IIA Cervical Cancer Who Previously Und NCT01101451 | GOG Foundation | Phase 3 |
| Completed | Temsirolimus in Treating Patients With Cervical Cancer That Is Recurrent, Locally Advanced, Metastatic, or Can NCT01026792 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurre NCT00803062 | National Cancer Institute (NCI) | Phase 3 |
| Terminated | Ixabepilone to Treat Cervical Cancer NCT00924066 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Glycoprotein and Glycan in Tissue and Blood Samples of Patients With Stage IB-IVA Cervical Cancer Undergoing S NCT00460356 | Gynecologic Oncology Group | — |
| Completed | ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer NCT00309959 | Gynecologic Oncology Group | Phase 2 |
| Completed | Bevacizumab, Radiation Therapy, and Cisplatin in Treating Patients With Previously Untreated Locally Advanced NCT00369122 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Pelvic Exenteration in Treating Patients With Recurrent Cervical Cancer NCT00217633 | Gynecologic Oncology Group | Phase 2 |
| Completed | Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage NCT00104910 | Gynecologic Oncology Group | Phase 1 |
| Terminated | Lymph Node Mapping and Sentinel Lymph Node Identification in Patients With Stage IB1 Cervical Cancer NCT00070317 | Gynecologic Oncology Group | N/A |
| Completed | Radiation Therapy Plus Cisplatin and Gemcitabine in Treating Patients With Cervical Cancer NCT00068549 | Gynecologic Oncology Group | Phase 1 |
| Completed | Comparison of Four Combination Chemotherapy Regimens Using Cisplatin in Treating Patients With Stage IVB, Recu NCT00064077 | Gynecologic Oncology Group | Phase 3 |
| Completed | Oxaliplatin and Paclitaxel in Treating Patients With Locally Recurrent or Metastatic Cervical Cancer NCT00057863 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Capecitabine in Treating Patients With Persistent or Recurrent Cervical Cancer NCT00039442 | Gynecologic Oncology Group | Phase 2 |
| Completed | Radiation Therapy and Cisplatin With or Without Epoetin Alfa in Treating Patients With Cervical Cancer and Ane NCT00017004 | Gynecologic Oncology Group | Phase 3 |
| Completed | Collecting Tumor Samples From Patients With Gynecological Tumors NCT00897442 | Gynecologic Oncology Group | — |